Follow us on Primrose Bio
"...With the merger complete, the potential for new manufacturing technologies that enable 21st-century vaccines and therapeutics really starts once the combined teams get their hands dirty in their new digs in San Diego and start collaborating, innovating, and combining the deep experience and track record of both sides into a new vision of biotechnology products." — Helge Zieler via Genetic Engineering & Biotechnology News #syntheticbiology #proteins #nucleicacids #therapeutics #biopharma